The ERCC1 C8092A polymorphism and grade III/IV gastrointestinal (GI) toxicity in non-small cell lung cancer (NSCLC) patients treated with chemoradiation

R Suk, S Gurubhagavatula, S Park, Wuding Zhou, L Su, T J Lynch, J C Wain, D Neuberg, G Liu, D C Christiani

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'The ERCC1 C8092A polymorphism and grade III/IV gastrointestinal (GI) toxicity in non-small cell lung cancer (NSCLC) patients treated with chemoradiation'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science